Recent Company News

• 06:38 AM ET Aug 18, 2026
  

  Tech, miners, industrials and financials the biggest laggards; retail, media, energy the best performers:

• 11:50 PM ET Aug 17, 2026
  

  SCHOTT Pharma upgraded to overweight from equal weight at Barclays (€21.60, 0.00)

• 10:21 AM ET Aug 12, 2026
  

  Transcript Intelligence: SCHOTT Pharma Q3 Earnings Themes

• 10:21 AM ET Aug 12, 2026
  

  Transcript Intelligence: SCHOTT Pharma Q3 Earnings Guidance

• 10:21 AM ET Aug 12, 2026
  

  Transcript Intelligence: SCHOTT Pharma Q3 Earnings Q&A

• 01:10 AM ET Aug 12, 2026
  

  SCHOTT Pharma reports Q3 EPS €0.26 vs FactSet €0.26 [4 est, €0.26-0.27]; confirms FY26 forecast (€22.40, 0.00)

• 05:27 PM ET Jul 09, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:56 AM ET Jul 09, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:40 AM ET Jul 09, 2026
  

  Basic resources, banks, tech, industrials and retail the top gainers; healthcare, food/beverage, autos and energy the main laggards:

• 04:36 AM ET Jul 09, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning